TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.
暂无分享，去创建一个
R. Catarino | D. Pinto | H. Sousa | C. Lopes | R. Medeiros | D. Pereira | Alexandra M. Santos | Catarina Portela | A. Araújo | C. Rodrigues | A. Santos